PubRank

W Irish

Author PubWeight™ 81.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994 4.16
2 Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998 2.31
3 A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 1995 2.09
4 Delayed graft function in the kidney transplant. Am J Transplant 2011 2.06
5 Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998 1.72
6 A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 1999 1.62
7 Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995 1.59
8 Weaning of immunosuppression in liver transplant recipients. Transplantation 1997 1.57
9 Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment Pharmacol Ther 2008 1.32
10 Current status of intestinal transplantation in children. J Pediatr Surg 1998 1.28
11 Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998 1.28
12 Infectious complications after small bowel transplantation in adults. Transplant Proc 1994 1.24
13 Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 1994 1.21
14 Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1999 1.19
15 Tacrolimus in pediatric renal transplantation. Transplantation 1996 1.18
16 Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 1993 1.18
17 Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994 1.16
18 Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995 1.16
19 A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant 1994 1.15
20 A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation 1999 1.14
21 A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc 1995 1.13
22 Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992 1.12
23 FK506 in pediatric kidney transplantation--primary and rescue experience. Pediatr Nephrol 1995 1.11
24 Tacrolimus in renal transplantation. Transplant Proc 1996 1.10
25 Factors determining the rate of referral, transplantation, and survival on dialysis in women with ESRD. Am J Kidney Dis 1997 1.08
26 Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995 1.05
27 Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation 1999 1.00
28 Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation 1995 0.99
29 Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. Transplantation 1994 0.98
30 Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant 2012 0.97
31 Predictive ability of pretransplant comorbidities to predict long-term graft loss and death. Am J Transplant 2008 0.97
32 Gastrointestinal bleeding after liver transplantation. Transplantation 1997 0.96
33 Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 1996 0.96
34 Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transpl Int 1994 0.95
35 Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. Transplant Proc 1994 0.94
36 One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc 1995 0.94
37 The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) 2001 0.93
38 A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1994 0.93
39 Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. Transplant Proc 1991 0.93
40 Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997 0.93
41 Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 1998 0.91
42 Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993 0.89
43 Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors. Am J Transplant 2007 0.87
44 Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg 1998 0.86
45 Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci 1998 0.86
46 Pediatric kidney transplantation at the University of Pittsburgh. Transplant Proc 1994 0.86
47 Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl Surg 1996 0.85
48 The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. Transfusion 1993 0.83
49 Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl 1993 0.83
50 Renal transplantation under FK 506 in African-Americans: early experience. Transplant Proc 1993 0.83
51 Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study. HIV Med 2005 0.83
52 Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation 1999 0.82
53 Improving results of pediatric renal transplantation. J Am Coll Surg 1994 0.82
54 "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation 1996 0.82
55 Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. Transplant Proc 1991 0.81
56 Long-term experience with everolimus in kidney transplantation in the United States. Transplant Proc 2011 0.81
57 Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis. Ther Drug Monit 1996 0.80
58 Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc 1995 0.80
59 Infectious complications after small bowel transplantation in adults: an update. Transplant Proc 1996 0.80
60 Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. Transplant Proc 1995 0.79
61 Evaluating glioma therapies: modeling treatments and predicting outcomes. J Natl Cancer Inst 1995 0.79
62 Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. Transplant Proc 1992 0.79
63 Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test. J Hepatol 1993 0.78
64 gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C. Hepatogastroenterology 1996 0.77
65 Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy. Ann N Y Acad Sci 1993 0.77
66 Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. Transplant Proc 1995 0.76
67 Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients. Transplant Proc 1999 0.76
68 Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation. Transplantation 1993 0.75
69 Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh. Transplant Proc 1993 0.75
70 Outcome of kidney transplantation in African-Americans using tacrolimus. Transplant Proc 1997 0.75
71 Influence of donor criteria on early outcome after intestinal transplantation. Transplant Proc 1997 0.75
72 Posttransplant hypertension in blacks versus nonblacks. Transplant Proc 1993 0.75
73 Use of a high-risk alcohol relapse scale in evaluating liver transplant candidates. Alcohol Clin Exp Res 2000 0.75
74 Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity 1994 0.75
75 Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation. Transplant Proc 1994 0.75
76 Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. Transplant Proc 1995 0.75
77 A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol 1998 0.75
78 Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. Transplant Proc 1993 0.75
79 Outcome of liver transplantation in critically ill patients with alcoholic cirrhosis: survival according to medical variables and sobriety. Transplantation 1998 0.75
80 A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. Transplant Proc 1999 0.75